Saturday 17 October 2026 Export PLSE’s income statement to Excel — free account

Pulse Biosciences, Inc

PLSE Healthcare Medical Instruments & Supplies

Pulse Biosciences, Inc’s revenue for fiscal 2025 (year ended December 2025) was $350,000.00, down 50.0% from fiscal 2022. In the quarter to June 2026, revenue grew 4,922.2%, EPS fell 28.6% and free cash flow fell 45.4%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

44.27 1.32 −2.90%

Follow PLSE

Alert me

Market cap: $3.3B
P/E: 0.0×
Fwd P/E: −19.0×
Dividend yield: —
F-score: n/a
Altman Z: 31.41
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	0.00	0.00	0.00	0.00	+8 more quarters Free account
P/S ratio Full definition →	1,619.34	1,978.44	1,526.95	1,517.45
P/FCF ratio Full definition →	0.00	0.00	0.00	0.00
P/Operating CF Full definition →	(102.57)	(100.58)	(62.71)	(91.47)
P/B ratio Full definition →	19.29	22.14	11.47	12.87
Price to Tangible BV Full definition →	19.89	23.27	11.97	13.38
EV/Sales Full definition →	1,589.11	1,975.05	1,502.31	1,480.03
EV/EBITDA Full definition →	0.00	0.00	0.00	0.00
EV/Operating CF Full definition →	(30.82)	(26.55)	(16.82)	(23.98)
EV/FCF Full definition →	(30.68)	(26.41)	(16.72)	(23.85)
Quick Ratio Full definition →	9.27	6.99	10.22	9.82
Current Ratio Full definition →	9.63	7.26	10.53	10.02
Net Debt/EBITDA Full definition →	4.06	3.62	4.49	4.73
Debt/Assets Full definition →	0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →	0.00	0.00	0.00	0.00
Asset Turnover Full definition →	0.01	0.01	0.01	0.01
Operating CF/Net income Full definition →	0.76	0.79	0.85	0.67
Capex/Depreciation Full definition →	(0.35)	(0.13)	(0.41)	(0.24)
Research and Development Expense of Revenue Full definition →	3,911.52%	3,139.65%	4,139.02%	13,247.67%
Selling, General and Administrative Expense of Revenue Full definition →	1,948.62%	1,643.64%	2,776.52%	10,210.47%
Intangible Assets out of Total Assets Full definition →	0.03	0.04	0.04	0.03
Share Based Compensation of Revenue Full definition →	1,145.85%	476.81%	1,882.58%	6,531.40%
Graham Net Nets Full definition →	0.05	0.04	0.08	0.07
Graham Number Full definition →	0.00	0.00	0.00	0.00
Earnings Yield Full definition →	(4.26%)	(5.09%)	(7.87%)	(6.38%)
Free Cash Flow Yield Full definition →	(3.20%)	(3.78%)	(5.88%)	(4.09%)
Revenue per Share Full definition →	0.01	0.01	0.00	0.00
Operating CF per Share Full definition →	(0.27)	(0.21)	(0.22)	(0.19)
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →	(0.27)	(0.22)	(0.22)	(0.19)
Cash per Share Full definition →	1.47	1.00	1.20	1.41
Shareholders Equity per Share Full definition →	1.44	0.98	1.20	1.38
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	1.44	0.98	1.20	1.38
Free Cash Flow Full definition →	(18.80)	(14.63)	(14.86)	(13.10)
Working Capital Full definition →	94.72	61.33	75.50	87.46
Capital Expenditures Full definition →	(0.09)	(0.03)	(0.10)	(0.06)
Net Current Asset Value Full definition →	89.64	55.81	69.54	81.09
EV/EBIT Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	0.21	0.08	0.40	0.72
Price to Operating Income Full definition →	0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →	0.06	0.08	0.15	0.04
Average Payables Full definition →	2.79	2.57	2.23	2.35
Average Inventory Full definition →	0.14	0.12	0.44	3.96
Average Assets Full definition →	117.91	107.50	113.50	100.91
Average Common Equity Full definition →	101.99	92.38	97.76	85.91

Fold the line items

Columns are period end dates

Stockrow Weekly